AML/ALL Flashcards
(38 cards)
AML – Acute myeloid leukemia
leukemic cells resemble cells of one or more myeloid lineages
ALL – Acute lymphoblastic leukemia
Leukemic cells - resemble precursor/immature lymphocytes
Etiology acute leukemia
Chromosomal abnormality, in PCR - block ability to differentiate/increase autonomy of growth signalling pathway
Risk factors for acute leukemia
Chemo (alkylating agent, topoisomerase II), ionizing, tabacco smoke, benzene, genetic syndrome
Acute leukemia clinical presentation
Anemia (fatigue, malaise, pallor, dyspnea)
Thrombocytopenia (brusing, petechiae, hemorrhage)
Neutropenia (fever, infection)
Rare: thrombotic events, DIC, skin/gum/tissues
___% of cases of ALL occur in children less than ___ y/o
75%; 6 y/o
Immaturity markers
CD34
Common immature lymphoblasts markers
TdT
B cell linage markers
CD19, CD22
T cell lineage markers
CD3, CD7
B cell mature markers
CD20, surface immunoglobulin
B-ALL accounts for _______ % of ALL, typically ALL of ____(age)___
80-85; childhood
BCR-ABL1 B-ALL
cytogenetics, distribution, prognosis
t(9;22) - philadelphia chromosome
“Ph+ALL”
25% of adult ALL, 2% childhood ALL
Poor prognosis
B-ALL MLL
translocation 11q23
Neonates/young infants
poor prognosis
B-ALL ETV6-RUNX1
t(12;21)
25% childhood B-ALL
Favorable prognosis
T-ALL traits
25% of ALL Adolescent/young adults Mediastinal mass High WBC Favors males
T-ALL prognosis general trends in children vs adults
Good - kids >95%, cure80% Poor adults Remission 60-80 Cure<50%
Poor ALL prognosis factors
< 1 y/o; >10 y/o Very high WBC T-lymphoblastic hypodiploidy Slow response to rx Min residual disease
AML - Acute myeloid leukemia occurs in what age?
adults (65 avg); 10% of childhood leukemia are AML
AML diagnosis
> 20% myeloblasts in marrow/peripheral blood
- morphologic appearance
- flow cytometric
- immunohistochemistry
Common myeloid markers
CD117 (C-Kit)
Myeloperoxidase
AML/APL - PML-RARA/M3 AML
t(15;17) Blocked at promyeloctyes (not at blasts) Hypergranular morphology Auer rods DIC
APL treatment
- RARA - retinotic acid receptor alpha protein - does not signal well –> accumulation of promyelocyte
Give high doses of ATRA to overcome
AML RUNX1-RUNX1T1
t(8;21)
5% AML - younger patient
Good prognosis